Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Double-blind Trial of Febuxostat vs Allopurinol in Hyperuricemia (Including Gout)
jRCT2080222060Phase 3
- Sponsor
- Astellas Pharma
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of febuxostat in hyperuricemia and gout (2 arms), sponsored by Astellas Pharma.
02
Drugs
febuxostat
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on jRCT2080222060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222060.